MedAI Verdict
Billing & coding

AI Medical Billing

Xsolis logo

Xsolis

by Xsolis  ·  founded 2013  ·  US

Last verified

Dragonfly by Xsolis: AI medical necessity, admission status and utilization management for hospitals and health plans.

At a glance

Pricing
No public price. CTA is "See how it works" and a consult request.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2013
HQ
US
On this page

Independent score  ·  By our public rubric

16/100Tracked

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    0/10

    No public HIPAA/SOC2/BAA attestation

  • Clinical Integration
    0/31.4

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    9/18

    Founded 2013 (13 years)

  • Sentiment & Transparency
    3.3/6.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/18

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    Seed-stage or unfunded

  • Years in market6/6

    Founded 2013 (13 years)

Sentiment & Transparency

  • Pricing transparency3/7

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

Dragonfly by Xsolis: AI medical necessity, admission status and utilization management for hospitals and health plans.

No public price. CTA is "See how it works" and a consult request.

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Xsolis record, https://medaiverdict.com/tools/xsolis, version November 2, 2026

Bottom line

Xsolis sells Dragonfly to hospitals and health plans, and the homepage frames it around medical necessity decisions, discharge planning and payer-provider collaboration. The vendor says the product was called CORTEX until a 2023 rebrand, and a PR Newswire release announced the Dragonfly launch at XCHANGE '24. Hospital utilization teams and plans are the audience, and a coding department hoping for code assignment is not who the Utilize page addresses. The modules are Dragonfly Utilize, Navigate and Revenue Integrity Insights.

What the Utilize page describes

The Utilize page calls the Care Level Score an "AI-driven medical necessity score" that "continuously pulls real-time data from the EMR to identify and prioritize patients," and lists admission decisions, continued stay and concurrent authorization, discharge planning and patient flow. It also describes "bidirectional (inbound and outbound) integration" with the EMR and names no EHR vendor.

The vendor says its generative AI initial review summarizes patient data and clinical notes into narratives that nurses review, edit and finalize, and claims an average saving of 10 minutes per review and payer response time cut in half. The about page timeline dates Precision Utilization Management, where providers and payers agree thresholds to automate authorizations, to 2018. Physician advisor services are a human service line.

Reported scale

The homepage claims "615+ Hospitals," "850+ Payer Connections," ">10B predictions," "5x-7x Average Customer ROI," "95% Client Retention Rate" and "Trusted ... for 13+ Years." The about page claims data on "440+ million unique encounters." The homepage does not say whether the 615 hospitals count Dragonfly users or all Xsolis services. The about page also cites a No. 1 ranking for Physician Advisory Services in the 2026 Best in KLAS Awards, for the fifth year.

Ownership and investors

Joan Butters, co-founder and CEO, and Jim Sohr founded Xsolis in 2013, and the about page says the team grew from 5 to over 275. Headquarters are in Franklin, Tennessee according to LinkedIn and CB Insights. The timeline records a US$75M minority growth investment from Brighton Park Capital in 2021. Aggregators also list SaaS Capital and Nashville Capital Network and put totals between US$75M (PitchBook, Tracxn) and US$79M (CB Insights).

PubMed's single hit for "Xsolis" is a 2018 protein aggregation paper with an author affiliated to the company, unrelated to Dragonfly.

Price: consult request only

Xsolis offers "See how it works" and a consult request in place of a price.

The verdict

Hospitals that need to defend admission status and health plans that want shared review thresholds match what the Utilize page and the 2018 Precision UM timeline entry describe. Coding departments and buyers wanting independent validation of the Care Level Score have little to evaluate on the site. Beacon Health, HonorHealth, Inova Health System, MLK Jr Community Hospital, UMC Health System and West Tennessee Healthcare are the named case studies.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. CTA is "See how it works" and a consult request.

Source: vendor pricing page. Last checked November 2, 2026.

Who builds it

Xsolis (Xsolis) was founded in 2013 in US, putting it 13 years into market.